• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.

作者信息

Boden W E, Bough E W, Reichman M J, Rich V B, Young P M, Korr K S, Shulman R S

出版信息

Circulation. 1985 Jun;71(6):1197-205. doi: 10.1161/01.cir.71.6.1197.

DOI:10.1161/01.cir.71.6.1197
PMID:2859931
Abstract

The effects of orally administered diltiazem combined with maximally tolerated doses of beta-blockers and nitrates were assessed in 12 patients, who during stress testing exhibited persistent effort angina and continued objective evidence for inducible myocardial ischemia. Patients performed multistage semisupine exercise on a bicycle ergometer during equilibrium-gated radionuclide angiography after consecutive 2 week treatment periods of placebo or diltiazem 90 mg qid (mean dose 340 mg/day) combined with maximally tolerated propranolol (mean dose 178 mg/day) and isosorbide dinitrate (mean dose 137 mg/day). All medications (including diltiazem or placebo) were administered four times daily for the duration of the study. Diltiazem or placebo was administered according to a double-blind design, with randomized cross-over at the end of each 2 week treatment period. The average number of angina attacks decreased during the double-blind cross-over phase of the trial (7 +/- 7 episodes/week at baseline vs 4 +/- 3 on placebo vs 2 +/- 2 on diltiazem; p = .08). Angina pectoris was abolished during peak exercise in eight of 12 patients on diltiazem (p less than .05 vs placebo). Diltiazem increased total exercise duration from 276 +/- 92 to 310 +/- 78 sec (p less than .005 vs baseline). Diltiazem likewise increased the time to onset of angina from 231 +/- 84 sec at baseline to 305 +/- 77 sec (p less than .005), as well as the time to the onset of 1 mm ischemic ST segment depression (p = .01). Diltiazem decreased heart rate at rest, during submaximal workload, and at peak exercise (p less than .05), and decreased systolic blood pressure at peak exercise only (p less than .05). A significant decline in rate-pressure product at submaximal and peak exercise was noted (p less than .05). At any given workload there was significantly less ST segment depression during submaximal (p = .05) and peak exercise (p less than .025).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Circulation. 1985 Jun;71(6):1197-205. doi: 10.1161/01.cir.71.6.1197.
2
Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.
Acta Pharmacol Toxicol (Copenh). 1985;57 Suppl 2:55-60. doi: 10.1111/j.1600-0773.1985.tb03575.x.
3
Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.接受β受体阻滞剂、长效硝酸盐类药物或两者联合治疗的患者,每日一次服用缓释地尔硫䓬的抗心绞痛反应。地尔硫䓬缓释片研究组。
Pharmacotherapy. 1997 Jul-Aug;17(4):760-6.
4
Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.地尔硫䓬、硝苯地平及其联合用药治疗稳定型心绞痛患者:对心绞痛、运动耐量及动态心电图ST段的影响
Circulation. 1988 Apr;77(4):774-86. doi: 10.1161/01.cir.77.4.774.
5
Short- and long-term efficacy of high-dose oral diltiazem for angina due to coronary artery disease: a placebo-controlled, randomized, double-blind crossover study.大剂量口服地尔硫䓬治疗冠状动脉疾病所致心绞痛的短期和长期疗效:一项安慰剂对照、随机、双盲交叉研究。
Circulation. 1983 Jul;68(1):139-47. doi: 10.1161/01.cir.68.1.139.
6
Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
Am J Cardiol. 1986 Jan 1;57(1):6-9. doi: 10.1016/0002-9149(86)90941-0.
7
Improved efficacy of high-dose versus medium- and low-dose diltiazem therapy for chronic stable angina pectoris.高剂量地尔硫䓬治疗慢性稳定型心绞痛较中低剂量疗效更佳。
Am J Cardiol. 1984 Mar 1;53(6):669-73. doi: 10.1016/0002-9149(84)90383-7.
8
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.雷诺嗪联合阿替洛尔、氨氯地平或地尔硫䓬对严重慢性心绞痛患者运动耐量和心绞痛发作频率的影响:一项随机对照试验。
JAMA. 2004 Jan 21;291(3):309-16. doi: 10.1001/jama.291.3.309.
9
[Effectiveness of various combination therapies in patients with coronary heart disease].[各种联合治疗对冠心病患者的疗效]
Herz. 1990 Dec;15(6):399-409.
10
Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls.高剂量地尔硫䓬治疗慢性稳定型心绞痛的长期疗效:与安慰剂对照的16个月系列研究。
Am Heart J. 1985 Jan;109(1):99-103. doi: 10.1016/0002-8703(85)90422-3.

引用本文的文献

1
Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy.在稳定型心绞痛患者中,联合治疗和三联疗法对经最佳β受体阻滞剂治疗后控制不佳的情况。
Neth Heart J. 2002 Nov;10(11):455-461.
2
Myocardial cell membrane stress ionic dyskinesia reversal by diltiazem.地尔硫䓬逆转心肌细胞膜应激性离子运动障碍
Exp Clin Cardiol. 2006 Fall;11(3):239-42.
3
The evolving role of medical therapy for chronic stable angina.药物治疗在慢性稳定型心绞痛中不断演变的作用。
Curr Cardiol Rep. 2008 Jul;10(4):263-71. doi: 10.1007/s11886-008-0044-y.
4
Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.氨氯地平或阿替洛尔单药治疗与联合治疗稳定型心绞痛的比较。
Clin Cardiol. 2000 Oct;23(10):763-70. doi: 10.1002/clc.4960231014.
5
Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.一种新型β受体阻滞剂塞利洛尔与钙拮抗剂地尔硫䓬和硝苯地平对房室传导的相互作用。
Cardiovasc Drugs Ther. 1995 Jun;9(3):445-57. doi: 10.1007/BF00879034.
6
Diltiazem. A review of its pharmacology and therapeutic use in older patients.地尔硫䓬。老年患者药理学及治疗应用综述。
Drugs Aging. 1993 Jul-Aug;3(4):363-90. doi: 10.2165/00002512-199303040-00007.
7
The efficacy and tolerance to three doses of diltiazem in elderly patients with stable angina.
Eur J Clin Pharmacol. 1988;33(6):561-4. doi: 10.1007/BF00542487.
8
Combination of nitrates with other antianginal drugs.硝酸盐与其他抗心绞痛药物的联合使用。
Drugs. 1987;33 Suppl 4:43-8. doi: 10.2165/00003495-198700334-00009.
9
Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.钙通道拮抗与β受体阻滞剂联合应用——心血管疾病的一种治疗选择。综述
Cardiovasc Drugs Ther. 1989 Jun;3(3):355-73. doi: 10.1007/BF01858108.
10
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.地尔硫䓬。对其药理特性和治疗用途的重新评估。
Drugs. 1990 May;39(5):757-806. doi: 10.2165/00003495-199039050-00009.